Keywords: EMA, CHMP, Osteoporosis, Calcitonin, Long-term use, Nasal spray

EMA unit recommends limiting long-term use of calcitonin medicines

Article | 22 July 2012

Print This

The European Medicines Agency said on Friday that its Committee for Medicinal Products for Human Use (CHMP) has recommended that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in